181 related articles for article (PubMed ID: 10069762)
1. Mechanisms of hypercoagulation in malignancy and during chemotherapy.
Falanga A
Haemostasis; 1998; 28 Suppl 3():50-60. PubMed ID: 10069762
[TBL] [Abstract][Full Text] [Related]
2. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
[TBL] [Abstract][Full Text] [Related]
3. The prothrombotic state in cancer: pathogenic mechanisms.
De Cicco M
Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
[TBL] [Abstract][Full Text] [Related]
4. Anticancer treatment and thrombosis.
Falanga A; Marchetti M
Thromb Res; 2012 Mar; 129(3):353-9. PubMed ID: 22119391
[TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis of the thrombophilic state in cancer patients.
Gouin-Thibault I; Samama MM
Semin Thromb Hemost; 1999; 25(2):167-72. PubMed ID: 10357084
[TBL] [Abstract][Full Text] [Related]
6. Thrombosis and hemostatic abnormalities in hematological malignancies.
Colombo R; Gallipoli P; Castelli R
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):441-50. PubMed ID: 25018062
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in oncology.
Falanga A; Vignoli A
Eksp Onkol; 2004 Mar; 26(1):11-4. PubMed ID: 15112573
[TBL] [Abstract][Full Text] [Related]
8. The hypercoagulable state of malignancy: pathogenesis and current debate.
Caine GJ; Stonelake PS; Lip GY; Kehoe ST
Neoplasia; 2002; 4(6):465-73. PubMed ID: 12407439
[TBL] [Abstract][Full Text] [Related]
9. Pathogenetic mechanisms of thrombosis in malignancy.
Donati MB; Falanga A
Acta Haematol; 2001; 106(1-2):18-24. PubMed ID: 11549773
[TBL] [Abstract][Full Text] [Related]
10. Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH.
Samuelson Bannow BT; Lee A; Khorana AA; Zwicker JI; Noble S; Ay C; Carrier M
J Thromb Haemost; 2018 Jun; 16(6):1246-1249. PubMed ID: 29737593
[No Abstract] [Full Text] [Related]
11. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis and cancer: 40 years of research.
Donati MB; Lorenzet R
Thromb Res; 2012 Mar; 129(3):348-52. PubMed ID: 22264938
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated thrombosis.
Zwicker JI; Furie BC; Furie B
Crit Rev Oncol Hematol; 2007 May; 62(2):126-36. PubMed ID: 17293122
[TBL] [Abstract][Full Text] [Related]
14. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
Falanga A; Marchetti M; Vignoli A; Balducci D
Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
[TBL] [Abstract][Full Text] [Related]
15. Thrombophilia in cancer.
Falanga A
Semin Thromb Hemost; 2005 Feb; 31(1):104-10. PubMed ID: 15706482
[TBL] [Abstract][Full Text] [Related]
16. Hematologic malignancies and thrombosis.
Elice F; Rodeghiero F
Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
[TBL] [Abstract][Full Text] [Related]
17. [The physiologic coagulation fibrinolytic system of the body and thrombohemorrhagic theory in oncology].
Nadiradze ISh; Machabeli MS
Usp Fiziol Nauk; 1989; 20(4):94-109. PubMed ID: 2688336
[No Abstract] [Full Text] [Related]
18. Coagulation and cancer: biological and clinical aspects.
Falanga A; Marchetti M; Vignoli A
J Thromb Haemost; 2013 Feb; 11(2):223-33. PubMed ID: 23279708
[TBL] [Abstract][Full Text] [Related]
19. The association between blood coagulation markers, atherothrombosis and dementia.
Gupta A; Pansari K
Int J Clin Pract; 2003 Mar; 57(2):107-11. PubMed ID: 12661793
[TBL] [Abstract][Full Text] [Related]
20. [Blood coagulation changes and neoplastic pathology].
Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D
Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]